Biosimilars Summit – Legal, Regulatory, and Commercial Strategies
June 24 - 25, 2019 | New York City
TO REGISTER, CLICK HERE »
Or call 888-224-2480
You can save an extra 10% off the current rate by using code D10-999-JDS19.
2019 marks the 9th anniversary of the Biologics Price Competition and Innovation Act (BPCIA). ACI has been with you from the introduction of the first House and Senate bills through to the actual signing of the law. As we prepare to enter the next decade of this iconoclastic law, we cordially invite you to join us for the 10th Anniversary edition of ACI’s Biosimilars Summit.
Join the “who’s who” of the biosimilars and innovator biologics industries as they gather in New York for ACI’s 2019 Summit on Biosimilars. Network with leading counsel representing both biosimilar and innovator companies at the industry’s one and only event directed to the legal, regulatory, and commercial aspects of the biosimilars marketplace.
Click here to learn more about this conference »
Download the conference agenda here »
Obtain insights from key industry stakeholders about the design and execution of effective biosimilars strategies.
Exclusive Interview with the FDA:
Joseph Franklin
Associate Director for Policy, Therapeutic Biologics and Biosimilars Staff
Office of New Drugs, CDER
U.S. Food & Drug Administration
The Honorable Jacqueline Bonilla
Deputy Chief Judge
Patent Trial and Appeal Board
U.S. Patent & Trademark Office
DISINGUISHED CO-CHAIRS:
Charles K. Sholtz
Director and Associate General Counsel
Biosimilars, Manufacturing & Litigation Readiness Lead
Genentech
Immac “Casey” Thampoe
Executive Director/Assistant General Counsel
IP Portfolio Development
Regeneron Pharmaceuticals, Inc.
FEATURED IN-HOUSE SPEAKERS
Derek Johnson
Senior Counsel Intellectual Property
Takeda Pharma
Kristan Lansbery
Sr Director, Asst GC, IP
Regeneron Pharmaceuticals, Inc.
Julia Pike
Vice President of Intellectual Property, North America
Sandoz
Tara Rahemba
Senior Director, Patent Counsel
Alexion Pharmaceuticals, Inc.
Laura Sim
Sr. Counsel
Development, Regulatory, Operations, &
Contracting Law
Amgen
Laura Storto
Assistant General Counsel, Associate Director
Genentech
Lori Wolfe
Assoc. General Counsel, North America IP Litigation
Teva Pharmaceuticals
Meet All the Speakers
Download the conference agenda here »
Obtain insights from key industry stakeholders about the design and execution of effective biosimilars strategies.
New Sessions for 2019:
-
Interchangeability: Insights into FDA’s Perspective on Implementation and the Future of Policy Development
-
The Economics of Biosimilar Drugs: New Considerations for Market Access, Sustainable Pricing and Reimbursement Policies
-
Global Focus on Biosimilars Abroad: From Patent Protection to Cost and Market Access
-
Challenging Patents on Reference Drugs and Establishing Standing: Litigation Strategies in the IPR Forum
-
The ITC: Examining the Role of this Alternate Forum in Biosimilars Disputes
-
The Growing Antitrust Scrutiny of Biosimilars and Biologics and Related Settlement Considerations
See the Complete Agenda here »
REGISTER NOW and save an extra 10% off the conference by using code D10-999-JDS19.
*Discount is valid for new registration only and it’s not applicable for workshops.
